Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.27 AUD | +0.40% | -0.39% | +7.63% |
Apr. 16 | XRF Scientific's Profit Before Tax Rises 15% in March Quarter | MT |
Feb. 20 | XRF Scientific Shares Decline 5% Despite Higher Fiscal H1 Revenue, EPS | MT |
Sales 2024 * | 59.1M 37.92M | Sales 2025 * | 63.8M 40.93M | Capitalization | 175M 113M |
---|---|---|---|---|---|
Net income 2024 * | 8M 5.13M | Net income 2025 * | 10M 6.42M | EV / Sales 2024 * | 2.78 x |
Net cash position 2024 * | 10.9M 6.99M | Net cash position 2025 * | 15.4M 9.88M | EV / Sales 2025 * | 2.51 x |
P/E ratio 2024 * |
19.5
x | P/E ratio 2025 * |
17.4
x | Employees | 48 |
Yield 2024 * |
2.44% | Yield 2025 * |
2.76% | Free-Float | 63.69% |
1 day | +0.40% | ||
1 week | -0.39% | ||
Current month | +3.25% | ||
1 month | +1.20% | ||
3 months | +19.25% | ||
6 months | +30.93% | ||
Current year | +7.63% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 08-05-31 | |
Andrew Watson
DFI | Director of Finance/CFO | - | 13-08-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Grimwade
CHM | Chairman | 66 | 12-04-30 |
David Kiggins
BRD | Director/Board Member | 54 | 12-04-30 |
David Brown
BRD | Director/Board Member | 86 | 04-06-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 1.27 | +0.40% | 319,752 |
24-04-18 | 1.265 | -0.39% | 78,166 |
24-04-17 | 1.27 | +0.79% | 84,118 |
24-04-16 | 1.26 | -0.79% | 140,239 |
24-04-15 | 1.27 | -0.39% | 49,756 |
Delayed Quote Australian S.E., April 19, 2024 at 02:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.63% | 113M | |
+20.19% | 27.81B | |
+25.07% | 5.31B | |
+24.06% | 4.62B | |
+29.84% | 1.72B | |
-18.38% | 1.05B | |
+4.42% | 1.04B | |
-39.47% | 854M | |
-9.32% | 709M | |
-22.49% | 300M |
- Stock Market
- Equities
- XRF Stock